vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and OFG BANCORP (OFG). Click either name above to swap in a different company.

OFG BANCORP is the larger business by last-quarter revenue ($184.3M vs $104.5M, roughly 1.8× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 0.9%). OFG BANCORP produced more free cash flow last quarter ($199.3M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 2.8%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

OFG Bancorp, founded in 1964, is the financial holding company for Oriental Bank, located in San Juan, Puerto Rico. OFG offers a wide range of retail and commercial banking, lending and wealth management products, services and technology, primarily in Puerto Rico and the U.S. Virgin Islands through its principal subsidiaries: Oriental Bank, Oriental Financial Services LLC, and Oriental Insurance LLC. Its headquarters are located at Oriental Center, 254 Muñoz Rivera Avenue, San Juan, PR 00918....

IMCR vs OFG — Head-to-Head

Bigger by revenue
OFG
OFG
1.8× larger
OFG
$184.3M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+23.4% gap
IMCR
24.3%
0.9%
OFG
More free cash flow
OFG
OFG
$234.9M more FCF
OFG
$199.3M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
2.8%
OFG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
OFG
OFG
Revenue
$104.5M
$184.3M
Net Profit
$55.9M
Gross Margin
97.4%
Operating Margin
-18.8%
25.7%
Net Margin
30.3%
Revenue YoY
24.3%
0.9%
Net Profit YoY
11.0%
EPS (diluted)
$-0.61
$1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
OFG
OFG
Q4 25
$104.5M
$184.3M
Q3 25
$103.7M
$186.2M
Q2 25
$98.0M
$182.4M
Q1 25
$93.9M
$178.6M
Q4 24
$84.1M
$182.7M
Q3 24
$80.2M
$174.7M
Q2 24
$75.4M
$179.8M
Q1 24
$70.5M
$174.4M
Net Profit
IMCR
IMCR
OFG
OFG
Q4 25
$55.9M
Q3 25
$-177.0K
$51.8M
Q2 25
$-10.3M
$51.8M
Q1 25
$5.0M
$45.6M
Q4 24
$50.3M
Q3 24
$8.7M
$47.0M
Q2 24
$-11.6M
$51.1M
Q1 24
$-24.4M
$49.7M
Gross Margin
IMCR
IMCR
OFG
OFG
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
IMCR
IMCR
OFG
OFG
Q4 25
-18.8%
25.7%
Q3 25
-6.9%
33.0%
Q2 25
-15.2%
36.1%
Q1 25
-3.9%
33.3%
Q4 24
-23.1%
28.9%
Q3 24
-10.6%
35.4%
Q2 24
-21.2%
39.6%
Q1 24
-37.6%
38.9%
Net Margin
IMCR
IMCR
OFG
OFG
Q4 25
30.3%
Q3 25
-0.2%
27.8%
Q2 25
-10.5%
28.4%
Q1 25
5.4%
25.5%
Q4 24
27.6%
Q3 24
10.9%
26.9%
Q2 24
-15.4%
28.4%
Q1 24
-34.7%
28.5%
EPS (diluted)
IMCR
IMCR
OFG
OFG
Q4 25
$-0.61
$1.27
Q3 25
$0.00
$1.16
Q2 25
$-0.20
$1.15
Q1 25
$0.10
$1.00
Q4 24
$-0.47
$1.10
Q3 24
$0.17
$1.00
Q2 24
$-0.23
$1.08
Q1 24
$-0.49
$1.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
OFG
OFG
Cash + ST InvestmentsLiquidity on hand
$864.2M
$1.0B
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$1.4B
Total Assets
$1.1B
$12.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
OFG
OFG
Q4 25
$864.2M
$1.0B
Q3 25
$892.4M
$740.3M
Q2 25
$882.8M
$851.8M
Q1 25
$837.0M
$710.6M
Q4 24
$820.4M
$591.1M
Q3 24
$901.3M
$680.6M
Q2 24
$859.6M
$740.4M
Q1 24
$832.8M
$754.4M
Total Debt
IMCR
IMCR
OFG
OFG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
OFG
OFG
Q4 25
$381.0M
$1.4B
Q3 25
$396.6M
$1.4B
Q2 25
$388.5M
$1.3B
Q1 25
$378.5M
$1.3B
Q4 24
$360.7M
$1.3B
Q3 24
$377.8M
$1.3B
Q2 24
$359.1M
$1.2B
Q1 24
$359.5M
$1.2B
Total Assets
IMCR
IMCR
OFG
OFG
Q4 25
$1.1B
$12.5B
Q3 25
$1.1B
$12.2B
Q2 25
$1.1B
$12.2B
Q1 25
$1.0B
$11.7B
Q4 24
$1.0B
$11.5B
Q3 24
$1.1B
$11.5B
Q2 24
$1.0B
$11.3B
Q1 24
$994.0M
$11.2B
Debt / Equity
IMCR
IMCR
OFG
OFG
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
OFG
OFG
Operating Cash FlowLast quarter
$-32.7M
$217.7M
Free Cash FlowOCF − Capex
$-35.5M
$199.3M
FCF MarginFCF / Revenue
-34.0%
108.1%
Capex IntensityCapex / Revenue
2.8%
10.0%
Cash ConversionOCF / Net Profit
3.90×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$345.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
OFG
OFG
Q4 25
$-32.7M
$217.7M
Q3 25
$-4.5M
$39.5M
Q2 25
$26.0M
$35.9M
Q1 25
$435.0K
$83.1M
Q4 24
$-14.0M
$252.5M
Q3 24
$21.1M
$58.1M
Q2 24
$23.5M
$95.1M
Q1 24
$-4.6M
$61.0M
Free Cash Flow
IMCR
IMCR
OFG
OFG
Q4 25
$-35.5M
$199.3M
Q3 25
$-5.2M
$35.5M
Q2 25
$25.6M
$31.8M
Q1 25
$137.0K
$78.7M
Q4 24
$-17.5M
$231.2M
Q3 24
$20.3M
$51.8M
Q2 24
$23.1M
$90.4M
Q1 24
$-5.0M
$54.8M
FCF Margin
IMCR
IMCR
OFG
OFG
Q4 25
-34.0%
108.1%
Q3 25
-5.0%
19.1%
Q2 25
26.1%
17.4%
Q1 25
0.1%
44.1%
Q4 24
-20.9%
126.5%
Q3 24
25.3%
29.6%
Q2 24
30.7%
50.3%
Q1 24
-7.1%
31.4%
Capex Intensity
IMCR
IMCR
OFG
OFG
Q4 25
2.8%
10.0%
Q3 25
0.7%
2.1%
Q2 25
0.4%
2.3%
Q1 25
0.3%
2.4%
Q4 24
4.3%
11.7%
Q3 24
1.0%
3.6%
Q2 24
0.4%
2.6%
Q1 24
0.6%
3.5%
Cash Conversion
IMCR
IMCR
OFG
OFG
Q4 25
3.90×
Q3 25
0.76×
Q2 25
0.69×
Q1 25
0.09×
1.82×
Q4 24
5.02×
Q3 24
2.42×
1.24×
Q2 24
1.86×
Q1 24
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons